Mogogest 250mg Injection
Marketer
Viziott Pharmaceuticals
Salt Composition
Hydroxyprogesterone (250mg)
Overview Mogogest 250mg Injection
Hydroxyprogesterone caproate 250mg injection helps prevent preterm labor in expectant mothers, thereby minimizing the chance of premature delivery. It aids in miscarriage prevention and reduces preterm birth risk in women with a prior history of premature birth. Administration is strictly by, or under the direct supervision of, a physician. Dosage and duration are determined solely by your doctor, and the injection should be used only as prescribed. Common side effects include injection site reactions, nausea, pruritus, diarrhea, and skin rash. Report any bothersome side effects to your physician; management strategies may be available. Because it can influence blood glucose, regular monitoring is essential. Immediately inform your doctor if you experience jaundice, dark urine, or abdominal pain. Prior to treatment, disclose any history of circulatory problems, diabetes, or liver disease. Comprehensive details of all other medications you are currently using should also be provided to your physician, as interactions may impact the drug's efficacy or mechanism of action.
Uses of Mogogest 250mg Injection
Avert Early Onset of Labor
Major Benefits of Mogogest 250mg Injection:
Administering this medication will be done by your physician or their qualified assistant; self-medication is strictly prohibited.
Common Side effects of Mogogest 250mg Injection:
- Injection site pain
- Injection site swelling
- Red spots or bumps
- Rash
How to use Mogogest 250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
How Mogogest 250mg Injection works:
Mogogest 250mg injectable solution contains a progestational agent.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Mogogest 250mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Mogogest 250mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Mogogest 250mg Injection is considered safe while breastfeeding. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent risk to the infant.
DrivingSAFE
Administration of Mogogest 250mg Injection typically does not impair driving capabilities.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Mogogest 250mg Injection to individuals with renal impairment. Physician consultation is advised. This medication's progesterone content may induce fluid retention in patients suffering from pre-existing kidney conditions.
LiverUNSAFE
Patients with liver impairment should likely avoid Mogogest 250mg Injection due to potential safety concerns. Medical advice is recommended.
What if you forget to take Mogogest 250mg Injection :
Omitting a scheduled Mogogest 250mg Injection warrants immediate physician consultation.
Facts to Know About Mogogest 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Glucocorticoids, Mineralocorticoids, and Progestins |
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
| Actions | First-Generation Progestins |
3,018 People bought this recently